Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.barrons.com/articles/mounjaro-ozempic-study-eli-lilly-novo-nordisk-d2bd9daf
0
0
Eli Lilly's Mounjaro Outperforms Novo Nordisk's Ozempic: New Study - Barron's
11/28/23 at 2:24pm
Organization
Barron's
Author
Josh Nathan-Kazis
Details
28 words
Summarize
Business & Industrial
News
Mounjaro Outperforms Novo Nordisk
Eli Lilly
Ozempic: New Study - Barron's
tirzepatide
It's the latest indication that Mounjaro is more effective than Ozempic for weight loss.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...